J.C. Penney sales continued acceleration in May at Cleveland Research Cleveland Research said J.C. Penney sales and traffic continued to accelerate in May driven by the reintroduction of circulars and coupons and that aggressive inventory control is resulting in positive channel commentary for June and July. The firm now expects Q2 comps of flat and EPS of (50c) vs. consensus (80c).
J&J recalling birth control pills outside U.S., AP reports Johnson & Johnson is conducting a voluntary recall of more than 32.2M packages of oral contraceptive Cilest distributed in 43 countries outside the U.S., reported The Associated Press. The drug is being recalled only from pharmacies and wholesalers and the company says there's a "very low" risk of the flawed pills causing unplanned pregnancies, AP said. Reference Link
Bristol-Myers price target raised to $54 from $46 at Argus Argus increased its price target on Bristol-Myers as the firm believes that the company has two products that appear to have the potential to treat a range of cancers. It keeps a Buy rating on the shares.
Stocks with call strike movement; JCP NFLX J.C. Penney (JCP) November 21 call option implied volatility decreased 2% to 52, Netflix (NFLX) June 270 call option implied volatility decreased 7% to 53 according to IVolatility.
J.C. Penney sales growth may resume by July, says JPMorgan JPMorgan said J.C. Penney comp sales growth may resume by July given easy year-over-year comps.
Subscribe for More Information
